/图文/东北制药集团/临床药理部/药品调查/
维格列汀和二甲双胍
治疗2型糖尿病新药——维格列汀-安富荣2012.pdf
治疗2型糖尿病的非胰岛素类药物的研究进展-刘永贵2013.pdf
暂时没用上Individualised-treatment-targets-for-elderly-patients-with-type-2-diabetes-using-vildagliptin-add-on-or-lone-therapy-INTERVAL-a-24-week-randomised-dou.pdf
用于环境水质分析的重金属检测技术.pdf
新型口服降糖药DPP-4抑制剂：从胰岛α细胞看2型糖尿病治疗的新进展-洪天配2012.pdf
五种上市DPP-4抑制剂的临床药动学比较-贾雪冬2014.pdf
维格列汀与二甲双胍联合治疗2 型糖尿病之疗效分析-曾龙驿2013.pdf
维格列汀与安慰剂比较治疗2 型糖尿病的Meta 分析-占美2011.pdf
维格列汀片说明书-诺华-1.jpg
维格列汀片（佳维乐）说明书.docx
维格列汀联用二甲双胍治疗2型糖尿病疗效和安全性的Meta分析_戴梦昭2013.pdf
维格列汀联合二甲双胍治疗老年2型糖尿病的临床疗效研究_陈协生2014.pdf
维格列汀联合二甲双胍治疗初发2型糖尿病的有效性研究-郝亚华2014.pdf
维格列汀联合二甲双胍治疗2型糖尿病的疗效与安全性的系统评价_刘金永2014.pdf
维格列汀联合二甲双胍与短期胰岛素_省略_全性以及对脂联素的影响的对比研究_叶海燕2014.caj
维格列汀结构式.jpg
维格列汀和二甲双胍联合用药对2型糖尿病的疗效观察_闫吉2013.caj
维格列汀——治疗2型糖尿病的新型口服降糖药-张儒雅2011.pdf
维格列汀P450代谢 英文Drug Metab Dispos-2009-He-536-44.pdf
维格列汀.docx
维格列汀 资料16.药理毒理研究资料综述.doc
维格列汀 28号-长春西汀注射液2015.1.15.docx
糖尿病治疗药研发新进展-黄胜炎2009.pdf
糖尿病药物治疗新靶点——维格列汀-卢林林2014.pdf
糖尿病新药研究进展-吴鸿2009.pdf
糖尿病.docx
抗糖尿病药物的药理研究进展-刘丽莹2009.pdf
抗糖尿病新药物维格列汀的研究进展-樊建领2012.pdf
抗糖尿病新药维格列汀-樊新星2008.pdf
聚远见 启未来——维格列汀VISION临床研究全国启动会在京召开-张希希2011.pdf
二肽基肽酶Ⅳ抑制剂治疗2型糖尿病的临床研究进展-吕小川2008.pdf
二甲双胍联合格列齐特或维格列汀降糖效果比较_尚敬2014.pdf
不同DPP-4抑制剂的构效关系和药代动力学特征-陈忻2014.pdf
Vildagliptin-A Review of Its Use in Type 2 Diabetes Mellitus .PDF
Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes-2012 IF 5.456.pdf
The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats-2011.pdf
Reduction of bo_20150115_13065777201879123_000.png
Prevalence and control of diabetes in Chinese adults.pdf
Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus.pdf
Individualised-treatment-targets-for-elderly-patients-with-type-2-diabetes-using-vildagliptin-add-on-or-lone-therapy-INTERVAL-a-24-week-randomised-dou.pdf
Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL)_ a 24 week
randomised
double-blind
placebo-controlled study.zip
GLP-1 类似物利拉鲁肽研究进展-侯永春2012.pdf
Global estimates of diabetes prevalence for 2013 and projections for 2035.pdf
Galvus
INN-vildagliptin 2014-12-18.pdf
Eucreas说明书.docx
Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes.pdf
Efficacy and tolerability of vildagliptin in drug‐naïve patients with type 2 diabetes and mild hyperglycaemia.pdf
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes，a 24 week
multicenter
randomized
double-blind
placebo-controlled
pa.pdf
DPP-4抑制剂的药代动力学特点-赵敏2011.pdf
db小鼠胰岛β细胞中的作用.pdf
Acute and Chronic Effects of the Incretin Enhancer Vildagliptin in Insulin-Resistant Rats-2005.pdf
2009年糖尿病领域研究进展和热点问题回顾-田勍2009.pdf
2 型糖尿病药物治疗新进展-张东来2011.pdf
000.png